Evidence map›Paper›PMID 40704021›Full record

ReviewMaterials today. Bio2025

Carbon dots: A promising tool for viral infection treatment.

Gangaraju Gedda, Chandra Lekha Putta, Anamika Verma, Sasvat Sayee Ram Ramesh, Wubshet Mekonnen Girma, Yoo-Jin Park, Aravind Kumar Rengan, Myung-Geol Pang

Abstract readReview
In one paragraph

Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gangaraju GeddaDepartment of Animal Science & Technology and BET Research Institute, Chung-Ang University, Anseong, Gyeonggi-do, 17546, Republic of Korea.
Chandra Lekha PuttaDepartment of Biomedical Engineering, Indian Institute of Technology Hyderabad, Sangareddy, Telangana, 502285, India.
Anamika VermaDepartment of Biomedical Engineering, Indian Institute of Technology Hyderabad, Sangareddy, Telangana, 502285, India.
Sasvat Sayee Ram RameshDepartment of Biomedical Engineering, Indian Institute of Technology Hyderabad, Sangareddy, Telangana, 502285, India.
Wubshet Mekonnen GirmaDepartment of Animal Science & Technology and BET Research Institute, Chung-Ang University, Anseong, Gyeonggi-do, 17546, Republic of Korea.
Yoo-Jin ParkDepartment of Animal Science & Technology and BET Research Institute, Chung-Ang University, Anseong, Gyeonggi-do, 17546, Republic of Korea.
Aravind Kumar RenganDepartment of Biomedical Engineering, Indian Institute of Technology Hyderabad, Sangareddy, Telangana, 502285, India.
Myung-Geol PangDepartment of Animal Science & Technology and BET Research Institute, Chung-Ang University, Anseong, Gyeonggi-do, 17546, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, viruses have impacted health, economy, and mental well-being of all humankind. Several advanced treatments and vaccines have been developed to overcome this problem. With the advancements in nanoscience and technology in the biomedical field, nanomaterials are now widely used in detection, diagnosis, and therapy. Carbon dots (CDs) have gained significant attention because of their remarkable physical, chemical, and biological properties. The bioactive features of CDs obtained from natural sources, including their antibacterial, anticancer, antiviral, and antioxidant capabilities, have been investigated. However, a broad scope exists to expand these studies and resolve the ambiguity in understanding the associated mechanisms. Hence, it is worth gathering knowledge regarding the potential natural sources of CDs that can help fight novel viral infections. In this review, we begin with a brief introduction in the first section, followed by an overview of viral structure, life cycle, modes of host entry, and current treatment strategies in the second section. The third section discusses the emergence of novel viruses. In the fourth and fifth sections, we examine the application of nanotechnology in managing viral infections, with particular emphasis on the use of CDs and their potential as protective agents against viral diseases. Section six highlights the challenges and limitations associated with the clinical application of CDs. Finally, we summarize the key findings and discuss the future prospects of CDs in antiviral therapy. This review is intended to serve as a valuable reference for the development of innovative treatment strategies against various viral infections.

Indexed as

Antiviral therapyCarbon dotsNatural precursorsProtective aidsVirus

Identifiers

PMID40704021
PMCPMC12284484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.